Organization: Dalhousie University

Human genome editing is not safe for clinical use, but nations must prepare: Report

A highly anticipated report says heritable genome editing, using tools like CRISPR to create edits that can be passed down to future generations, is not yet safe enough for clinical use. But it also provides specific guidance on how nations should prepare for the eventual use of CRISPR or other gene editing tools, defining a translational pathway from research to the clinic.

The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more

Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…

Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics

The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.

Survey: Canadian universities are increasingly cutting fossil fuels from their investment portfolios

A growing number of Canadian universities, including some of the country’s largest, are significantly reducing the industrial carbon in their investment portfolios, a R$ survey shows. Less than a handful of universities are divesting specifically from fossil fuel holdings, but many schools also are using a “responsible investing” approach which considers environmental, social and governance factors.